drugset / Trial / NCT00598897
Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease
Phase 4
Completed
89 enrolled
The University of Texas Health Science Center at Tyler
Abbott · collabPfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
To determine the safety and tolerance of clarithromycin given three times per week in combination with multiple drugs including rifabutin three times per week
Timeline
- Start
- 1995-08
- Primary completion
- 2002-08-07
- Completion
- 2017-05-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clarithromycin | Small molecule | — | — |
| Subject | Rifabutin | Small molecule | — | — |